SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MANGALAM DRUGS & ORGANICS

BSE: 532637 22 Aug 2025
Healthcare
₹ 80.06
Mangalam Drugs and Organics Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MANGALAM DRUGS & ORGANICS - Share Price & Details

Market Cap
₹123.0
High /Low
145.0 / 65.5
Stock P/E
17.7
Book Value
₹93.9
Dividend Yield
0.0
ROCE
8.2
ROE
₹4.76
Face Value
10.0
PEG Ratio
-0.6
EVEBITDA
₹5.77
Debt
89.2
CMP / FCF
11.0
Debt to equity
₹0.6
NP Ann
6.92
High price all time
442.0
Piotroski score
₹7.0
Graham Number
96.1
No. Eq. Shares
1.58
Net CF
₹1.57
Net profit
6.92
Price to book value
0.83
Interest Coverage
₹1.33
Low price all time
3.43
Industry PE
31.6
Reserves
₹133
Free Cash Flow
₹23.3

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
MANGALAM DRUGS & ORGANICS LTD.573.49-137.28573.49-8.67123.017.7
Achyut Healthcare LimitedNANANANA118214.0
Murae Organisor Limited5,155.3428.545,155.340.0311715.5

Peer Comparison Chart


About MANGALAM DRUGS & ORGANICS

Mangalam Drugs and Organics Ltd., with Security Code 532637, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Mangalam Drugs and Organics reports standalone net loss of Rs 13.73 crore in the June 2025 quarter

(08 Aug 2025)
Net loss of Mangalam Drugs and Organics reported to Rs 13.73 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore...
Read more →

Mangalam Drugs Reports Quarterly Loss Amid Financial Challenges

(08 Aug 2025)
Mangalam Drugs & Organics Ltd. ( ($IN:MANGALAM) ) has issued an update. Mangalam Drugs & Organics Ltd. announced the approval of its un-audited financial...
Read more →

Mangalam Drugs and Organics reports consolidated net loss of Rs 13.80 crore in the June 2025 quarter

(08 Aug 2025)
Net loss of Mangalam Drugs and Organics reported to Rs 13.80 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore...
Read more →

Mangalam Drugs Reports Q1 Financial Results with Notable Loss

(08 Aug 2025)
Mangalam Drugs & Organics Ltd. ( ($IN:MANGALAM) ) has provided an update. Mangalam Drugs & Organics Ltd. announced the approval of its unaudited financial...
Read more →

Organics Limited (MANGALAM) Announces Strategic Shift - Accelerated wealth expansion

(24 Jul 2025)
Organics Limited (MANGALAM) Announces Strategic Shift ✌️【Stock Trends】✌️ Professional-grade analytics and free investment tips in one...
Read more →

Mangalam Drugs and Organics to declare Quarterly Result

(23 Jul 2025)
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 August 2024.
Read more →

Company Updates